Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cantaloupe (CTLP) Accumulated Expenses (2016 - 2025)

Cantaloupe (CTLP) has disclosed Accumulated Expenses for 15 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 21.17% to $25.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.3 million, a 21.17% increase, with the full-year FY2025 number at $19.7 million, down 17.74% from a year prior.
  • Accumulated Expenses was $25.3 million for Q4 2025 at Cantaloupe, up from $22.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $29.5 million in Q4 2022 to a low of $17.5 million in Q1 2025.
  • A 5-year average of $25.1 million and a median of $26.0 million in 2021 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 21.17% in 2025; the steepest drop was 29.53% in 2025.
  • Cantaloupe's Accumulated Expenses stood at $28.7 million in 2021, then grew by 2.62% to $29.5 million in 2022, then decreased by 8.55% to $27.0 million in 2023, then dropped by 22.4% to $20.9 million in 2024, then grew by 21.17% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for CTLP's Accumulated Expenses are $25.3 million (Q4 2025), $22.5 million (Q3 2025), and $19.7 million (Q2 2025).